Posted on 2/27/2024
AviClear® is now available in select practices in the United Kingdom, Europe, and Australia.
Cutera announces the international limited commercial release of AviClear® at IMCAS World Congress 2024
BRISBANE, California, February 8, 2024 – CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment o...